FDAClass II · Medical device · Recalled May 13, 2026

Medline Convenience Kits recall — Medline Industries, LP

Hazard: Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

Class II: may cause temporary or medically reversible health consequences.

View the official FDA enforcement record (openFDA) ↗

Official recall ID: Z-2096-2026
Brand: Medline Industries
Classification: Class II
Units affected: 3508 units
Recall status: Ongoing
Initiated: Voluntary: Firm initiated

Description

Medline Convenience Kits: 1) DYNDA3003, Model Number: DENTAL PACK; 2) DYNJ87157, Model Number: GULLO SURGICAL PACK

Affected products

Medline Convenience Kits

Companies & origin

Recalling firm location: Northfield, IL, United States
Firm address: 3 Lakes Dr, 60093-2753

Identifying details (verbatim from the notice)

Product codes / lots: 1) DYNDA3003, UDI-DI: 10195327257484(each), 40195327257485(case), Lot Number: 22JBH446; 2) DYNDA3003, UDI-DI: 10195327257484(each), 40195327257485(case), Lot Number: 23ABA768; 3) DYNDA3003, UDI-DI: 10195327257484(each), 40195327257485(case), Lot Number: 23BBS986; 4) DYNDA3003, UDI-DI: 10195327257484(each), 40195327257485(case), Lot Number: 23CBN951; 5) DYNDA3003, UDI-DI: 10195327257484(each), 40195327257485(case), Lot Number: 23CBT510; 6) DYNDA3003, UDI-DI: 10195327257484(each), 40195327257485(case), Lot Number: 23CBV199; 7) DYNDA3003, UDI-DI: 10195327257484(each), 40195327257485(case), Lot Number: 23GBA134; 8) DYNDA3003, UDI-DI: 10195327257484(each), 40195327257485(case), Lot Number: 23JBH393; 9) DYNDA3003, UDI-DI: 10195327257484(each), 40195327257485(case), Lot Number: 24BBH600; 10) DYNDA3003, UDI-DI: 10195327257484(each), 40195327257485(case), Lot Number: 24CMF059; 11) DYNDA3003, UDI-DI: 10195327257484(each), 40195327257485(case), Lot Number: 24CMF059A; 12) DYNDA3003, UDI-DI: 10195327257484(each), 40195327257485(case), Lot Number: 24EMC989; 13) DYNDA3003, UDI-DI: 10195327257484(each), 40195327257485(case), Lot Number: 24HME376; 14) DYNDA3003, UDI-DI: 10195327257484(each), 40195327257485(case), Lot Number: 24JMG165; 15) DYNDA3003, UDI-DI: 10195327257484(each), 40195327257485(case), Lot Number: 24KMH629; 16) DYNDA3003, UDI-DI: 10195327257484(each), 40195327257485(case), Lot Number: 25AMD692; 17) DYNDA3003, UDI-DI: 10195327257484(each), 40195327257485(case), Lot Number: 25EMB013; 18) DYNDA3003, UDI-DI: 10195327257484(each), 40195327257485(case), Lot Number: 25FMI462; 19) DYNDA3003, UDI-DI: 10195327257484(each), 40195327257485(case), Lot Number: 25HMH340; 20) DYNJ87157, UDI-DI: 10198459014482(each), 40198459014483(case), Lot Number: 24ILA361
Distribution: Worldwide - US Nationwide distribution.
Firm notified the public via: Letter
FDA event ID: 98642
Recall initiated: January 7, 2026
FDA classified: May 7, 2026
FDA report date: May 13, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 24, 2026 at 3:00 AM UTC.

Report a data error on this page